Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 6.0M | $8.4M | -8% | Sep 2025 |
|
| BML Capital Management | 5.3M | $7.4M | 6% | Sep 2025 |
|
| Tang Capital Management | 4.8M | $6.7M | 100% | Sep 2025 |
|
| Arrowpoint Asset Management | 3.3M | $4.6M | 4% | Sep 2025 |
|
| Sio Capital Management | 2.6M | $3.7M | -29% | Sep 2025 |
|
| Euclidean Capital | 2.6M | $3.7M | 0% | Sep 2025 |
|
| Vanguard Group | 2.2M | $3.0M | 0% | Sep 2025 |
|
| Acadian Asset Management | 2.1M | $2.9M | 0% | Sep 2025 |
|
| Stonepine Capital Management | 1.4M | $1.9M | 62% | Sep 2025 |
|
| BlackRock | 1.1M | $1.5M | -3% | Sep 2025 |
|
| Marshall Wace | 613k | $858k | 100% | Sep 2025 |
|
| Aldebaran Capital | 504k | $706k | -2% | Sep 2025 |
|
| Geode Capital Management | 432k | $605k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 418k | $585k | -14% | Sep 2025 |
|
| Jane Street | 382k | $535k | 100% | Sep 2025 |
|
| Northern Trust | 381k | $533k | 229% | Sep 2025 |
|
| Bridgeway Capital Management | 321k | $449k | 115% | Sep 2025 |
|
| Walleye Trading Advisors | 279k | $390k | 258% | Sep 2025 |
|
| Two Sigma Investments | 270k | $378k | -7% | Sep 2025 |
|
| Rbf Capital | 246k | $344k | 0% | Sep 2025 |
|
| Peapod Lane Capital | 203k | $284k | -55% | Sep 2025 |
|
| Boothbay Fund Management | 202k | $282k | 100% | Sep 2025 |
|
| Citadel Advisors | 193k | $271k | -25% | Sep 2025 |
|
| Goldman Sachs Group | 171k | $239k | 89% | Sep 2025 |
|
| State Street Corporation | 158k | $221k | 0% | Sep 2025 |
|
| Evoke Wealth | 133k | $186k | 0% | Sep 2025 |
|
| Assenagon Asset Management | 123k | $172k | -53% | Sep 2025 |
|
| ADAR1 Capital Management | 101k | $141k | 0% | Sep 2025 |
|
| Ikarian Capital | 98k | $137k | 100% | Sep 2025 |
|
| PanAgora Asset Management | 72k | $101k | -17% | Sep 2025 |
|
| Pnc Financial Services | 71k | $99k | 17% | Sep 2025 |
|
| Jacobs Levy Equity Management | 69k | $96k | 100% | Sep 2025 |
|
| Algert Coldiron Investors | 62k | $87k | 100% | Sep 2025 |
|
| D. E. Shaw & Co | 56k | $78k | -91% | Sep 2025 |
|
| Rangeley Capital | 46k | $64k | 100% | Sep 2025 |
|
| Cubist Systematic Strategies | 44k | $61k | 100% | Sep 2025 |
|
| XTX Topco | 43k | $60k | 100% | Sep 2025 |
|
| Velan Capital Investment Management | 35k | $49k | 0% | Sep 2025 |
|
| Morgan Stanley | 34k | $36k | 100% | Jun 2025 |
|
| Hsbc Holdings | 31k | $43k | 0% | Sep 2025 |
|
| Barclays | 28k | $39k | -9% | Sep 2025 |
|
| Susquehanna International | 26k | $36k | -43% | Sep 2025 |
|
| Simplex Trading | 21k | $29k | 29113% | Sep 2025 |
|
| Pathstone Holdings | 18k | $25k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 16k | $22k | -1% | Sep 2025 |
|
| Squarepoint Ops | 13k | $18k | -37% | Sep 2025 |
|
| Independent Advisor Alliance | 13k | $18k | 0% | Sep 2025 |
|
| Diadema Partners | 11k | $16k | 100% | Sep 2025 |
|
| Ameriprise Financial | 11k | $15k | 100% | Sep 2025 |
|
| Gts Securities | 10k | $14k | 100% | Sep 2025 |
|
| Deerfield Management Company | 8.8k | $12k | 0% | Sep 2025 |
|
| Ohio Pers | 6.1k | $8.5k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 4.1k | $11k | 801% | Sep 2025 |
|
| UBS Group | 1.6k | $2.2k | -99% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $1.5k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 914.00 | $1.3k | -92% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 545.00 | $763.000000 | 0% | Sep 2025 |
|
| Cloud Capital Management | 29.00 | $0 | 100% | Sep 2025 |
|
| Caitong International Asset Management | 20.00 | $28.000000 | 100% | Sep 2025 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Sep 2025 |
|
Who sold out of Pmv Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alkeon Capital Management | Jun 2025 | 2.3M | $2.5M |
| Shay Capital | Jun 2025 | 24k | $26k |
| Millennium Management | Jun 2025 | 24k | $25k |
| Hrt Financial | Jun 2025 | 22k | $23k |
| Schonfeld Strategic Advisors | Jun 2025 | 22k | $24k |
| CI Private Wealth | Jun 2025 | 10k | $11k |
| Group One Trading | Jun 2025 | 7.4k | $7.8k |
| Tower Research Capital | Jun 2025 | 3.7k | $3.9k |
| Raymond James Financial | Jun 2025 | 200.00 | $212.000000 |